Jump to content Jump to main menu Jump to sub menu


4 November 2010 - QED appoints PharmaTimes Clinical Recruiter of the year 2010 Finalist as Head of Resourcing


QED is pleased to announce the appointment of Dave Gilchrist as Head of Resourcing.  Dave has over a decade of experience in recruitment, in various industries including Commerical, IT and Pharmaceutical.  Read more »

10 September 2010 - QED – Biotech’s Favourite CRO

QED today announced its vision and strategy for 2011.  Given QED’s continued success and growth predominantly within the Biotech sector and re-affirming our positioning as a partner of choice in this area, the company has tailored its service provision appropriately.  Read more »

29 June 2010 - QED awarded Phase II Biomarker study

QED is very pleased to announce the award of an important phase II study looking at biomarkers of inflammation.  This dose ranging study is planned to run for approximately 16 months and will recruit more than 300 patients at several commercial sites across the UK.  QED Director UK Operations, Susan Ollier, said “Our wealth of experience working with Biotech sponsors and across early phase research enables QED to effectively manage this trial.”

22 October 2010 - QED launches new website

As part of QED’s continued Business Development and Marketing efforts, we are pleased to announce a major re-design to our website Read more »

13 August 2010 - QED further strengthens Phase I experience

QED is pleased to announce that it has been awarded another phase I trial from a top 5 pharmaceutical sponsor.  This now brings the total to 6 phase I studies that QED has worked on for this sponsor under our MSA with them.  Read more »

7 June 2010 - QED adds Data Management & Biostatistics

In a strategic move to provide full-service to all of our customers, QED has signed a strategic alliance agreement with i-clinics, a specialised clinical software company located in Brussels, Belgium. Read more »